|Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial|
SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ...
European heart journal 33 (22), 2821-2830, 2012
|Sex differences in mortality following acute coronary syndromes|
JS Berger, L Elliott, D Gallup, M Roe, CB Granger, PW Armstrong, ...
Jama 302 (8), 874-882, 2009
|Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in …|
EM Hylek, C Held, JH Alexander, RD Lopes, R De Caterina, DM Wojdyla, ...
Journal of the American College of Cardiology 63 (20), 2141-2147, 2014
|Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial|
S Halvorsen, D Atar, H Yang, R De Caterina, C Erol, D Garcia, ...
European heart journal 35 (28), 1864-1872, 2014
|The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation|
EC O'Brien, DJN Simon, LE Thomas, EM Hylek, BJ Gersh, JE Ansell, ...
European heart journal 36 (46), 3258-3264, 2015
|Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II Registry|
BA Steinberg, P Shrader, L Thomas, J Ansell, GC Fonarow, BJ Gersh, ...
Journal of the American College of Cardiology 68 (24), 2597-2604, 2016
|Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry|
SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ...
Journal of the American College of Cardiology 72 (4), 351-366, 2018
|Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed …|
BA Steinberg, ED Peterson, S Kim, L Thomas, BJ Gersh, GC Fonarow, ...
Circulation 131 (5), 488-494, 2015
|Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis|
T Yates, SM Haffner, PJ Schulte, L Thomas, KM Huffman, CW Bales, ...
The Lancet 383 (9922), 1059-1066, 2014
|Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry|
SD Pokorney, DJN Simon, L Thomas, GC Fonarow, PR Kowey, P Chang, ...
American heart journal 170 (1), 141-148. e1, 2015
|Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation|
L Wallentin, RD Lopes, M Hanna, L Thomas, A Hellkamp, S Nepal, ...
Circulation 127 (22), 2166-2176, 2013
|Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial|
JH Alexander, RD Lopes, L Thomas, M Alings, D Atar, P Aylward, S Goto, ...
European heart journal 35 (4), 224-232, 2014
|Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial|
SM Al-Khatib, L Thomas, L Wallentin, RD Lopes, B Gersh, D Garcia, ...
European heart journal 34 (31), 2464-2471, 2013
|Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures|
D Garcia, JH Alexander, L Wallentin, DM Wojdyla, L Thomas, M Hanna, ...
Blood, The Journal of the American Society of Hematology 124 (25), 3692-3698, 2014
|Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF|
JP Piccini, ES Fraulo, JE Ansell, GC Fonarow, BJ Gersh, AS Go, EM Hylek, ...
American heart journal 162 (4), 606-612. e1, 2011
|Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial|
RD Lopes, LE Elliott, HD White, JS Hochman, F Van de Werf, D Ardissino, ...
European heart journal 30 (16), 2019-2028, 2009
|Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular …|
S Subherwal, ED Peterson, D Dai, L Thomas, JC Messenger, Y Xian, ...
Journal of the American College of Cardiology 59 (21), 1861-1869, 2012
|Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation …|
JV Freeman, DJN Simon, AS Go, J Spertus, GC Fonarow, BJ Gersh, ...
Circulation: Cardiovascular Quality and Outcomes 8 (4), 393-402, 2015
|Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial|
C Held, EM Hylek, JH Alexander, M Hanna, RD Lopes, DM Wojdyla, ...
European heart journal 36 (20), 1264-1272, 2015
|Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed …|
BA Steinberg, S Kim, JP Piccini, GC Fonarow, RD Lopes, L Thomas, ...
Circulation 128 (7), 721-728, 2013